Citation: Lr. Wiseman et A. Fitton, Cabergoline: a review of its efficacy in the treatment of Parkinson's Disease (vol 12, pg 485, 1999), CNS DRUGS, 13(3), 2000, pp. 213-213
Citation: Cr. Culy et al., Oxaliplatin - A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies, DRUGS, 60(4), 2000, pp. 895-924
Citation: Lr. Wiseman et D. Faulds, Daclizumab: A review of its use in the prevention of acute rejection in renal transplant patients (vol 58, pg 1029, 1999), DRUGS, 59(3), 2000, pp. 476-476
Citation: Lr. Wiseman et A. Fitton, Cabergoline - A review of its efficacy in the treatment of Parkinson's disease, CNS DRUGS, 12(6), 1999, pp. 485-497
Authors:
Wiseman, LR
Adkins, JC
Plosker, GL
Goa, KL
Citation: Lr. Wiseman et al., Oxaliplatin - A review of its use in the management of metastatic colorectal cancer, DRUG AGING, 14(6), 1999, pp. 459-475
Citation: Lr. Wiseman et D. Faulds, Daclizumab - A review of its use in the prevention of acute rejection in renal transplant recipients, DRUGS, 58(6), 1999, pp. 1029-1042
Citation: W. Mcneely et Lr. Wiseman, Intranasal azelastine: a review of its efficacy in the management of allergic rhinitis (vol 56, pg 91, 1998), DRUGS, 57(1), 1999, pp. 8-8
Citation: Rh. Foster et Lr. Wiseman, Abciximab: an updated review of its use in ischaemic heart disease (vol 56, pg 629, 1998), DRUGS, 57(1), 1999, pp. 91-91